GlassScriptPhysician profile
Casey Kee Hardison
NPI 1902526163
$447.35
in general payments reported to CMS, 2019-2025
15 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $151 · 2024: $142 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $447.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $81.43 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $51.43 | 2025 | |
| Pfizer INC. | $50.99 | 2023 | |
| Akebia Therapeutics INC | $36.80 | 2024-2025 | Vafseo, Auryxia |
| Boston Scientific Corporation | $31.79 | 2023 | Watchman Flx |
| Alexion Pharmaceuticals, INC. | $31.03 | 2024 | Ultomiris |
| Novo Nordisk INC | $23.84 | 2025 | Rivfloza |
| Calliditas Therapeutics US INC. | $22.06 | 2025 | Tarpeyo |
| Glaxosmithkline, LLC. | $20.22 | 2024 | Benlysta |
| Genentech USA, INC. | $19.70 | 2025 | Gazyva |
| Biotronik INC. | $18.17 | 2023 | Biomonitor |
| Amgen INC. | $16.09 | 2024 | Tavneos |
| Travere Therapeutics, INC. | $15.49 | 2025 | |
| Aurinia Pharma U.S., INC. | $14.39 | 2024 | Lupkynis |
| Kowa Pharmaceuticals America, INC. | $13.92 | 2023 | Livalo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Hardison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.